{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:24:40Z","timestamp":1780478680452,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High blood pressure is a prevalent condition in patients with chronic kidney disease on hemodialysis. Adequate control of high blood pressure is essential to reducing deaths in this group. The present study aimed to observe mortality prospectively in a group of patients in hemodialysis and hemodiafiltration programs in whom the use of antihypertensives was optimized with the point-of-care dry weight (POC-DW) technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present observational, prospective study was carried out at the Pafram hemodiafiltration unit in Morona Santiago, Ecuador, and the hemodialysis unit of the Fundaci\u00f3n Renal del Ecuador in Guayaquil, Ecuador, from August 2019 to December 2023. Patients who were receiving hemodiafiltration were included. Weight was optimized with POC-DW for eight weeks. In Group 1, patients whose use of antihypertensive drugs was not required to control systolic blood pressure with a value less than 150 mmHg predialysis, less than 130 mmHg postdialysis, and a peridialytic blood pressure (defined as post-HD minus pre-HD SBP) between 0 and \u2212\u200920 mmHg were analyzed. In Group 2, patients who required antihypertensive drugs for not meeting the aims of systolic blood pressure were included. The variables included clinical, demographic, mortality, description of the treatment, and routine laboratory tests in dialysis programs. The sample was nonprobabilistic. Survival analysis was performed for the study groups. The log-rank test (Mantel-Cox) was used for survival comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 106 patients. Optimal blood pressure control without antihypertensive treatment was achieved in 52 patients (49.1%) (Group 1). In 54 patients (50.9%), antihypertensive agents were required (Group 2). There was more significant mortality in the group that received antihypertensives: 11 patients in group 1 (21.2%) versus 25 patients in group 2 (46.3%) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005). Survival was more significant in group 1, with an HR of 2.2163 (1.125\u20134.158) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0243).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In hemodiafiltration and hemodialysis programs, blood pressure control with active ultrafiltration measures and without using antihypertensives is essential for survival in patients with CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-03948-0","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T12:15:55Z","timestamp":1737116155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-3420","authenticated-orcid":false,"given":"Franklin Geovany","family":"Mora-Bravo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-989X","authenticated-orcid":false,"given":"Pamela Tatiana Morales","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7811-6308","authenticated-orcid":false,"given":"Nelson Rojas","family":"Campoverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7989-9122","authenticated-orcid":false,"given":"Guillermina Luc\u00eda Blum","family":"Carcelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-2196","authenticated-orcid":false,"given":"Juan Cristobal Santacruz","family":"Mancheno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-4447","authenticated-orcid":false,"given":"\u00c1ngel Crist\u00f3bal Santacruz","family":"Tipanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Perez-Grovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-3964","authenticated-orcid":false,"given":"Willan Patricio Robles","family":"Abarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"3948_CR1","doi-asserted-by":"publisher","unstructured":"Symonides B, Lewandowski J, Ma\u0142yszko J. Resistant hypertension in dialysis. Nephrol Dial Transplant. 2023;38(9):1952\u20131959. https:\/\/doi.org\/10.1093\/ndt\/gfad047. PMID: 36898677.","DOI":"10.1093\/ndt\/gfad047"},{"issue":"24","key":"3948_CR2","doi-asserted-by":"publisher","first-page":"17550","DOI":"10.3390\/ijms242417550","volume":"24","author":"C Ulrich","year":"2023","unstructured":"Ulrich C, Canim Z, Herberger E, Girndt M, Fiedler R. Inflammation in Hypervolemic Hemodialysis patients: the roles of RelB and Caspase-4. Int J Mol Sci. 2023;24(24):17550. https:\/\/doi.org\/10.3390\/ijms242417550. PMID: 38139378; PMCID: PMC10743509.","journal-title":"Int J Mol Sci"},{"key":"3948_CR3","doi-asserted-by":"publisher","unstructured":"Hecking M, Schmiedecker M, Waller M, Gil SL, Bieber B, Jean G, Chazot C. Active fluid management in Tassin\/France of the 21st century and outcomes. Kidney Int. 2022;102(6):1427\u20131428. https:\/\/doi.org\/10.1016\/j.kint.2022.09.010. PMID: 36411021.","DOI":"10.1016\/j.kint.2022.09.010"},{"issue":"12","key":"3948_CR4","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1093\/ndt\/gfaa182","volume":"36","author":"C Loutradis","year":"2021","unstructured":"Loutradis C, Sarafidis PA, Ferro CJ, Zoccali C. Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management. Nephrol Dial Transpl. 2021;36(12):2182\u201393. https:\/\/doi.org\/10.1093\/ndt\/gfaa182. PMID: 33184659; PMCID: PMC8643589.","journal-title":"Nephrol Dial Transpl"},{"key":"3948_CR5","doi-asserted-by":"publisher","unstructured":"See EJ, Polkinghorne KR. Volume management in haemodialysis patients. Curr Opin Nephrol Hypertens. 2020;29(6):663\u2013670. https:\/\/doi.org\/10.1097\/MNH.0000000000000642. PMID: 32889978.","DOI":"10.1097\/MNH.0000000000000642"},{"issue":"3","key":"3948_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/sdi.12586","volume":"30","author":"DC Miskulin","year":"2017","unstructured":"Miskulin DC, Weiner DE. Blood pressure management in Hemodialysis patients: what we know and what questions remain. Semin Dial. 2017;30(3):203\u201312. https:\/\/doi.org\/10.1111\/sdi.12586. Epub 2017 Mar 6. PMID: 28264150.","journal-title":"Semin Dial"},{"issue":"7","key":"3948_CR7","doi-asserted-by":"publisher","first-page":"e27058","DOI":"10.7759\/cureus.27058","volume":"14","author":"R Rabbani","year":"2022","unstructured":"Rabbani R, Noel E, Boyle S, Balina H, Ali S, Fayoda B, Khan WA. Role of Antihypertensives in end-stage renal disease: a systematic review. Cureus. 2022;14(7):e27058. https:\/\/doi.org\/10.7759\/cureus.27058. PMID: 36000139; PMCID: PMC9389027.","journal-title":"Cureus"},{"key":"3948_CR8","doi-asserted-by":"publisher","unstructured":"Wang CH, Negoianu D, Zhang H, Casper S, Hsu JY, Kotanko P, Raimann J, Dember LM. Dynamics of plasma Refill Rate and Intradialytic Hypotension during Hemodialysis: Retrospective Cohort Study with Causal Methodology. Kidney360. 2023;4(4):e505\u201314. https:\/\/doi.org\/10.34067\/KID.0000000000000082. Epub 2023 Feb 14. PMID: 36790867; PMCID: PMC10278774.","DOI":"10.34067\/KID.0000000000000082"},{"issue":"9","key":"3948_CR9","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/ndt\/gfz289","volume":"35","author":"H Zhang","year":"2020","unstructured":"Zhang H, Preciado P, Wang Y, Meyring-Wosten A, Raimann JG, Kooman JP, van der Sande FM, Usvyat LA, Maddux D, Maddux FW, Kotanko P. Association of all-cause mortality with pre-dialysis systolic blood pressure and its peridialytic change in chronic hemodialysis patients. Nephrol Dial Transpl. 2020;35(9):1602\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfz289. PMID: 32003794; PMCID: PMC7473807.","journal-title":"Nephrol Dial Transpl"},{"issue":"37","key":"3948_CR10","doi-asserted-by":"publisher","first-page":"e22002","DOI":"10.1097\/MD.0000000000022002","volume":"99","author":"Y Shimamura","year":"2020","unstructured":"Shimamura Y, Maeda T, Abe K, Takizawa H. Association of blood pressure with mortality in hemodialysis patients with a tunneled cuffed catheter: a single-center observational study. Med (Baltim). 2020;99(37):e22002. https:\/\/doi.org\/10.1097\/MD.0000000000022002. PMID: 32925731; PMCID: PMC7489610.","journal-title":"Med (Baltim)"},{"issue":"3","key":"3948_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ajh\/hpw114","volume":"30","author":"PI Georgianos","year":"2017","unstructured":"Georgianos PI, Agarwal R. Blood pressure and mortality in Long-Term Hemodialysis-Time to Move Forward. Am J Hypertens. 2017;30(3):211\u201322. https:\/\/doi.org\/10.1093\/ajh\/hpw114. PMID: 27661097; PMCID: PMC5861571.","journal-title":"Am J Hypertens"},{"issue":"8","key":"3948_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJMoa2304820","volume":"389","author":"PJ Blankestijn","year":"2023","unstructured":"Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, Barth C, Covic A, Cromm K, Cucui A, Davenport A, Rose M, T\u00f6r\u00f6k M, Woodward M, Bots ML, CONVINCE Scientific Committee Investigators. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med. 2023;389(8):700\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2304820. Epub 2023 Jun 16. PMID: 37326323.","journal-title":"N Engl J Med"},{"key":"3948_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2369-13-106","volume":"13","author":"FG Mora-Bravo","year":"2012","unstructured":"Mora-Bravo FG, De-La-Cruz G, Rivera S, Ram\u00edrez AM, Raimann JG, P\u00e9rez-Grovas H. Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective cohort study. BMC Nephrol. 2012;13:106. https:\/\/doi.org\/10.1186\/1471-2369-13-106. PMID: 22963170; PMCID: PMC3575237.","journal-title":"BMC Nephrol"},{"issue":"1","key":"3948_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1681\/ASN.2017020135","volume":"29","author":"DC Miskulin","year":"2018","unstructured":"Miskulin DC, Gassman J, Schrader R, Gul A, Jhamb M, Ploth DW, Negrea L, Kwong RY, Levey AS, Singh AK, Harford A, Paine S, Kendrick C, Rahman M, Zager P. BP in Dialysis: results of a pilot study. J Am Soc Nephrol. 2018;29(1):307\u201316. Epub 2017 Dec 6. PMID: 29212839; PMCID: PMC5748902.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3948_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/aor.12133","volume":"38","author":"SC Rivera-Gonz\u00e1lez","year":"2014","unstructured":"Rivera-Gonz\u00e1lez SC, P\u00e9rez-Grovas H, Madero M, Mora-Bravo F, Saavedra N, L\u00f3pez-Rodriguez J, Lerma C. Identification of impeding factors for dry weight achievement in end-stage renal disease after appropriate kidney graft function. Artif Organs. 2014;38(2):113\u201320. https:\/\/doi.org\/10.1111\/aor.12133. Epub 2013 Jul 25. PMID: 23889479.","journal-title":"Artif Organs"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-03948-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03948-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T12:15:59Z","timestamp":1737116159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-03948-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3948"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-03948-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4054177\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Ecuatorian Society of Nephrology approved this study. Informed consent was obtained from all participating subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"30"}}